CI vs TRDA
Cigna Corp (CI) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
CI currently screens at market cap $71.62B and trailing P/E 2.4. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the CI and TRDA stock pages for the full models.
Not investment advice.